title: A case of iatrogenic severe mitral regurgitation.
abstract: Bromocriptine and cabergoline, ergot derived dopamine receptor agonists used to treat Parkinson's disease and prolactinomas, have been associated with increased risk of cardiac valve disease. Here we present a case of iatrogenic symptomatic severe mitral regurgitation due to these drugs.
authors.forename: Antonio
authors.initials: A
authors.lastname: D'Aloia
authors.forename: Barbara
authors.initials: B
authors.lastname: Piovanelli
authors.forename: Riccardo
authors.initials: R
authors.lastname: Rovetta
authors.forename: Ivano
authors.initials: I
authors.lastname: Bonadei
authors.forename: Enrico
authors.initials: E
authors.lastname: Vizzardi
authors.forename: Antonio
authors.initials: A
authors.lastname: Curnis
authors.forename: Marco
authors.initials: M
authors.lastname: Metra
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001971:Bromocriptine / Q000008:administration & dosage / Q000009:adverse effects*; D000077465:Cabergoline; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000008:administration & dosage / Q000009:adverse effects*; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation; D006727:Hormone Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000139:chemically induced* / Q000601:surgery; D010911:Pituitary Neoplasms / Q000188:drug therapy; D015175:Prolactinoma / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D004873:Ergolines; D006727:Hormone Antagonists; D001971:Bromocriptine; D000077465:Cabergoline